Hemogenyx Pharmaceuticals to issue convertible loan notes

1 week ago 1

Hemogenyx Pharmaceuticals (OTCPK:HOPHF) issued convertible loan notes as the company continues the clinical trial of HG-CT-1, its CAR-T cell therapy for relapsed or refractory acute myeloid leukemia.
The company was approached by a small investor group offering to provide